pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
NC-410
Cervical Cancer
$NXTC
NextCure, Inc.
0
catalysts
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
0
catalysts
Phase 2
ND-10 ER
Myopia
Theialife Sciences Pvt Ltd
0
catalysts
Phase 2
NEO-100
Recurrent Glioblastoma Multiforme (GBM)
← prev
page 20 of 53
next →
131
Pain
89
Neurology
1
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
Phase 2
NEO-212
Astrocytoma
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
Phase 2
NG-350A
Epithelial Tumor
Akamis Bio Ltd
0
catalysts
Phase 2
NGGT-002
Phenylketonuria (PKU)
Next Generation Gene Therapeutics Inc
0
catalysts
Phase 2
NMDP-02
ignaseclant
Spinal Muscular Atrophy (SMA)
NMD Pharma AS
0
catalysts
Phase 2
NMDP-08
ignaseclant
Charcot-Marie-Tooth Disease Type I
NMD Pharma AS
0
catalysts
Phase 2
NOUS-209
Gastric Cancer
Nouscom AG
0
catalysts
Phase 2
NP-213
Novexatin
Onychomycosis (Tinea Unguium)
Novabiotics Ltd
0
catalysts
Phase 2
NRT-023
Post Partum Depression (Maternal Depression / Postnatal Depression)
Nanjing Noratech Pharmaceutical Inc
0
catalysts
Phase 2
NS-050
Duchenne Muscular Dystrophy
NS Pharma Inc
0
catalysts
Phase 2
NS-229
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Nippon Shinyaku Co Ltd
0
catalysts
Phase 2
NT-101
Wet (Neovascular / Exudative) Macular Degeneration
NexThera Co Ltd
0
catalysts
Phase 2
NT-219
Metastatic Colorectal Cancer
$PPBT
PURPLE BIOTECH LTD.
0
catalysts
Phase 2
NTCDM-3
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Destiny Pharma Ltd
0
catalysts
Phase 2
NTM-006
Post-Operative Pain
Neumentum Inc
0
catalysts
Phase 2
NTX-1472
Social Anxiety Disorder (SAD/Social Phobia)
Newleos Therapeutics Inc
0
catalysts
Phase 2
NTX-301
Chronic Myelomonocytic Leukemia (CMML)
Pinotbio Inc
0
catalysts
Phase 2
NVG-291
Chronic Spinal Cord Injury
$NGEN
NERVGEN PHARMA CORP.
0
catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0
catalysts
Phase 2
NVX-208
perflenapent
Acute Ischemic Stroke
NuvOx Pharma LLC
0
catalysts
Phase 2
NX-210c
Amyotrophic Lateral Sclerosis
Axoltis Pharma SAS
0
catalysts
Phase 2
NanoDOX
Wounds
Resilience Government Services Inc
0
catalysts
Phase 2
Nerofe
Refractory Acute Myeloid Leukemia
Immune System Key Ltd
0
catalysts
Phase 2
Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
Norovirus Infections
$VXRT
Vaxart, Inc.
0
catalysts
Phase 2
NouvNeu-001
Parkinson's Disease
iRegene Therapeutics Co Ltd
0
catalysts
Phase 2
Nov-DB2
Obesity
NovMetaPharma Co Ltd
0
catalysts
Phase 2
NovOB
Obesity
DNA gyrase
NovMetaPharma Co Ltd
0
catalysts
